Ascendis Pharma's total assets for Q1 2025 were €1.06B, a decrease of -10.01% from the previous quarter. ASND total liabilities were €1.25B for the fiscal quarter, a -2.64% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.